MARIA FOY: Open Payments
NPI 1932162880 · OREGON CITY, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169 in 7 payments from 7 companies in 2025. Trend: 2023 $417 · 2024 $21 · 2025 $169
Food & beverage: $169
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Lilly USA, LLC | 1 | $22 |
Products named: OTEZLA, REXULTI, SHINGRIX, Ozempic, ELIQUIS, BREZTRI, ZEPBOUND.
Industry payments across OR — which companies pay providers there.
